First Trust Bloomberg R&D Leaders ETF (RND) Institutional Ownership $25.63 -0.28 (-1.08%) As of 06/13/2025 04:10 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Institutional Ownership Changes (13F Filings) for First Trust Bloomberg R&D Leaders ETF (NYSEARCA:RND)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$384.27KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$676.37K Get RND Insider Trade Alerts Want to know when executives and insiders are buying or selling First Trust Bloomberg R&D Leaders ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address First Trust Bloomberg R&D Leaders ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2025 Brio Consultants LLC15,990$361K0.1%N/A15.990% 5/5/2025 IFP Advisors Inc1,872$42K0.0%+128.0%1.872% 2/14/2025 Tower Research Capital LLC TRC13,374$332K0.0%-65.6%0.000% 2/13/2025 Concentrum Wealth Management15,990$397K0.1%-9.9%0.000% (Data available from 1/1/2016 forward) RND Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RND shares? During the previous two years, the following institutional investors and hedge funds held shares of First Trust Bloomberg R&D Leaders ETF shares: Concentrum Wealth Management ($397K), Brio Consultants LLC ($361K), and Tower Research Capital LLC TRC ($332K), IFP Advisors Inc ($42K).Learn more on RND's institutional investors. Which institutional investors have been buying First Trust Bloomberg R&D Leaders ETF stock? The following institutional investors have purchased First Trust Bloomberg R&D Leaders ETF stock in the last 24 months: Brio Consultants LLC ($15.99K), and IFP Advisors Inc ($1.05K). How much institutional buying is happening at First Trust Bloomberg R&D Leaders ETF? Institutional investors have bought a total of 17,041 shares in the last 24 months. This purchase volume represents approximately $384.27K in transactions. Which First Trust Bloomberg R&D Leaders ETF major shareholders have been selling company stock? The following institutional investors have sold First Trust Bloomberg R&D Leaders ETF stock in the last 24 months: Tower Research Capital LLC TRC ($25.48K), and Concentrum Wealth Management ($1.75K). How much institutional selling is happening at First Trust Bloomberg R&D Leaders ETF? Institutional investors have sold a total of 27,229 shares in the last 24 months. This volume of shares sold represents approximately $676.37K in transactions. Related Companies SPDR MSCI USA Climate Paris Aligned ETF Institutional Ownership Global X Interest Rate Hedge ETF Institutional Ownership Tema Luxury ETF Institutional Ownership KraneShares Global Luxury Index ETF Institutional Ownership Amplify Thematic All-Stars ETF Institutional Ownership ProShares Decline of the Retail Store ETF Institutional Ownership KraneShares 100% KWEB Defined Outcome Through January 2026 ETF Institutional Ownership Gabelli Growth Innovators ETF Institutional Ownership First Trust Indxx Metaverse ETF Institutional Ownership Amplify Weight Loss Drug & Treatment ETF Institutional Ownership This page (NYSEARCA:RND) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Bloomberg R&D Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Bloomberg R&D Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
